广泛耐多药肺结核与同肺癌,无药可治,预后很差,对家庭和社会构成严重威胁,目前全球有50 000万以上的患者正受耐多药结核分枝杆菌感染。WHO估计当今仍有2/3患者正处于发生耐多药甚至广泛耐药病例中。在结核病耐药形式严峻、新药开发困难的情况下,我们借助其他领域的用药,来治疗 Extensive multidrug-resistant tuberculosis and lung cancer with no cure and poor prognosis pose a serious threat to the family and society. Currently, more than 50 million patients worldwide are receiving multidrug-resistant Mycobacterium tuberculosis infection. WHO estimates that two-thirds of today’s patients are still in the midst of multidrug-resistant and even multi-drug resistant cases. In the grim form of drug resistance in tuberculosis, new drug development difficulties, we use other areas of medication to treat